Skip to main content

Table 2 Frequency of antibiotics and their days of therapy (DOT)

From: Characteristics of patients infected with Clostridioides difficile at a Saudi Tertiary Academic Medical Center and assessment of antibiotic duration

Antibiotic N (%) DOT (median [IQR])
All antibiotics 159 (100) 17.5 [12.25–26.5]
Piperacillin/tazobactam 62 (39) 14 [5.75–40.5]
Ceftriaxone 60 (37.7) 14 [5–43.25]
Meropenem 59 (37.1) 14 [7–26]
Ciprofloxacin 50 (31.4) 26 [8.75–56.5]
Cefuroxime 37 (23.3) 14 [7.5–44.5]
Gentamicin 18 (11.3) 18 [5.75–44]
Imipenem/cilastatin 19 (11.9) 11 [4–29]
Ceftazidime 17 (10.7) 14 [4.5–40]
Amoxicillin/clavulanic acid 15 (9.4) 10 [9–26]
Clarithromycin 14 (8.8) 11.5 [7.75–34.5]
Clindamycin 14 (8.8) 27 [9.75–58]
Trimethoprim/sulfamethoxazole 12 (7.5) 9.5 [4.25–62.25]
Cefazolin 12 (7.5) 13 [7.5–16.25]
Cloxacillin 10 (6.3) 37 [10.75–58.25]
Moxifloxacin 9 (5.7) 38 [10–61]
Azithromycin 7 (4.4) 26 [5–58]
Erythromycin 7 (4.4) 47 [3–56]
Rifampin 5 (3.1) 7 [5.5–36]
Amikacin 4 (2.5) 35 [10.75–54]
Ampicillin 4 (2.5) 6 [2–10.75]
Cefepime 4 (2.5) 17.5 [9–55.25]
Tigecycyline 4 (2.5) 30 [7–53.25]
Colistimethate sodium 3 (1.9) 26 [9–29]
Flucloxacillin 2 (1.3) 17–30a
Ofloxacin 2 (1.3) 38-49a
Doxycycline 1 (0.6) 3
Levofloxacin 1 (0.6) 21
  1. aRange